A Dose-Finding Study of GSK2894512 Cream in Subjects With Atopic Dermatitis (AD)

PHASE2CompletedINTERVENTIONAL
Enrollment

247

Participants

Timeline

Start Date

December 1, 2015

Primary Completion Date

January 1, 2017

Study Completion Date

January 12, 2017

Conditions
Dermatitis, Atopic
Interventions
DRUG

GSK2894512 1% Cream

1.0% (10 mg/g) GSK2894512 will be supplied as white to off-white cream to be applied topically

DRUG

GSK2894512 0.5% Cream

0.5% (5 mg/g) GSK2894512 will be supplied as white to off-white cream to be applied topically

DRUG

Vehicle cream

White to off-white vehicle cream base to be applied topically

Trial Locations (60)

2910

GSK Investigational Site, Cranston

10022

GSK Investigational Site, New York

15213

GSK Investigational Site, Pittsburgh

19103

GSK Investigational Site, Philadelphia

23507

GSK Investigational Site, Norfolk

27262

GSK Investigational Site, High Point

29650

GSK Investigational Site, Greer

30342

GSK Investigational Site, Atlanta

45255

GSK Investigational Site, Cincinnati

46256

GSK Investigational Site, Indianapolis

47150

GSK Investigational Site, New Albany

48322

GSK Investigational Site, West Bloomfield

48706

GSK Investigational Site, Bay City

55432

GSK Investigational Site, Fridley

60118

GSK Investigational Site, West Dundee

60611

GSK Investigational Site, Chicago

64506

GSK Investigational Site, Saint Joseph

66215

GSK Investigational Site, Overland Park

70115

GSK Investigational Site, New Orleans

72916

GSK Investigational Site, Fort Smith

75230

GSK Investigational Site, Dallas

75231

GSK Investigational Site, Dallas

77004

GSK Investigational Site, Houston

77056

GSK Investigational Site, Houston

77598

GSK Investigational Site, Webster

78218

GSK Investigational Site, San Antonio

78229

GSK Investigational Site, San Antonio

80220

GSK Investigational Site, Denver

90045

GSK Investigational Site, Los Angeles

92056

GSK Investigational Site, Oceanside

92697

GSK Investigational Site, Irvine

92701

GSK Investigational Site, Santa Ana

98101

GSK Investigational Site, Seattle

93720-2933

GSK Investigational Site, Fresno

06032

GSK Investigational Site, North Logan

01810

GSK Investigational Site, Andover

V3R 6A7

GSK Investigational Site, Surrey

L3P1X2

GSK Investigational Site, Markham

L6J 7W5

GSK Investigational Site, Oakville

K2G 6E2

GSK Investigational Site, Ottawa

K9J5K2

GSK Investigational Site, Peterborough

L4B 1A5

GSK Investigational Site, Richmond Hill

N2J 1C4

GSK Investigational Site, Waterloo

N8W 5L7

GSK Investigational Site, Windsor

J2B 5L4

GSK Investigational Site, Drummondville

G1V4X7

GSK Investigational Site, Québec

813-0044

GSK Investigational Site, Fukuoka

819-0373

GSK Investigational Site, Fukuoka

003-0026

GSK Investigational Site, Hokkaido

006-0022

GSK Investigational Site, Hokkaido

211-0063

GSK Investigational Site, Kanagawa

220-0004

GSK Investigational Site, Kanagawa

221-0825

GSK Investigational Site, Kanagawa

861-3101

GSK Investigational Site, Kumamoto

572-0838

GSK Investigational Site, Osaka

593-8324

GSK Investigational Site, Osaka

133-0057

GSK Investigational Site, Tokyo

169-0075

GSK Investigational Site, Tokyo

194-0013

GSK Investigational Site, Tokyo

203-0003

GSK Investigational Site, Tokyo

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY